60
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Detection of tumour DNA in serum of colorectal cancer patients

, , , , , & show all
Pages 601-604 | Received 04 Jul 1997, Accepted 05 Aug 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ian A Cree. (2016) Progress and potential of RAS mutation detection for diagnostics and companion diagnostics. Expert Review of Molecular Diagnostics 16:10, pages 1067-1072.
Read now
Yang Li, Xiao-Hong Fu, Jin-Qiu Yuan, Zu-Yao Yang, Chen Mao, Xiao-Mei Dong, Jin-Ling Tang & Sheng-Yong Wang. (2015) Colorectal cancer: using blood samples and tumor tissue to detect K-ras mutations. Expert Review of Anticancer Therapy 15:6, pages 715-725.
Read now

Articles from other publishers (40)

Ryan Cohen, Cameron F Platell, Melanie J McCoy, Katie Meehan & Kathy Fuller. (2023) Circulating tumour DNA in colorectal cancer management. British Journal of Surgery 110:7, pages 773-783.
Crossref
Thomas L. Sutton, Ranish K. Patel, Ashley N. Anderson, Stephen G. Bowden, Riley Whalen, Nicole R. Giske & Melissa H. Wong. (2022) Circulating Cells with Macrophage-like Characteristics in Cancer: The Importance of Circulating Neoplastic-Immune Hybrid Cells in Cancer. Cancers 14:16, pages 3871.
Crossref
Thomas L. Sutton, Brett S. Walker & Melissa H. Wong. (2019) Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers. Cellular and Molecular Gastroenterology and Hepatology 8:4, pages 595-607.
Crossref
Luai R. Zarour, Sudarshan Anand, Kevin G. Billingsley, William H. Bisson, Andrea Cercek, Michael F. Clarke, Lisa M. Coussens, Charles E. Gast, Cristina B. Geltzeiler, Lissi Hansen, Katherine A. Kelley, Charles D. Lopez, Shushan R. Rana, Rebecca Ruhl, V. Liana Tsikitis, Gina M. Vaccaro, Melissa H. Wong & Skye C. Mayo. (2017) Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cellular and Molecular Gastroenterology and Hepatology 3:2, pages 163-173.
Crossref
Samantha Perakis, Martina Auer, Jelena Belic & Ellen Heitzer. 2017. 73 153 .
Peter Ulz, Armin Gerger, Jelena Belic & Ellen Heitzer. (2016) Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients. LaboratoriumsMedizin 40:5, pages 323-334.
Crossref
Irena Hudecova. (2015) Digital PCR analysis of circulating nucleic acids. Clinical Biochemistry 48:15, pages 948-956.
Crossref
Maria Gonzalez-Pons & Marcia Cruz-Correa. (2015) Colorectal Cancer Biomarkers: Where Are We Now?. BioMed Research International 2015, pages 1-14.
Crossref
Linda J.W. Bosch, Beatriz Carvalho, Remond J.A. Fijneman, Connie R. Jimenez, Herbert M. Pinedo, Manon van Engeland & Gerrit A. Meijer. (2011) Molecular Tests for Colorectal Cancer Screening. Clinical Colorectal Cancer 10:1, pages 8-23.
Crossref
Matthew R. Pincus, Paul W. Brandt-Rauf, Martin H. Bluth & Wilbur B. Bowne. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods 1400 1414 .
T. Lecomte, N. Ceze, É. Dorval & P. Laurent-Puig. (2010) Circulating free tumor DNA and colorectal cancer. Gastroentérologie Clinique et Biologique 34:12, pages 662-681.
Crossref
Bozena Dobrzycka, Slawomir J. Terlikowski, Andrzej Mazurek, Oksana Kowalczuk, Wieslawa Niklinska, Lech Chyczewski & Marek Kulikowski. (2010) Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer. International Journal of Cancer 127:3, pages 612-621.
Crossref
Marwan M. Fakih. (2010) KRAS Mutation Screening in Colorectal Cancer: From Paper to Practice. Clinical Colorectal Cancer 9:1, pages 22-30.
Crossref
Jacqueline Amanda Shaw & Karen Page. 2009. Handbook of Nucleic Acid Purification. Handbook of Nucleic Acid Purification.
David B. Solit, Iman Osman, David Polsky, Katherine S. Panageas, Adil Daud, James S. Goydos, Jerrold Teitcher, Jedd D. Wolchok, F. Joseph Germino, Susan E. Krown, Daniel Coit, Neal Rosen & Paul B. Chapman. (2008) Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma. Clinical Cancer Research 14:24, pages 8302-8307.
Crossref
M. Fleischhacker & B. Schmidt. (2007) Circulating nucleic acids (CNAs) and cancer—A survey. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1775:1, pages 181-232.
Crossref
C. Trevisiol, F. Di Fabio, R. Nascimbeni, L. Peloso, C. Salbe, E. Ferruzzi, B. Salerni & M. Gion. (2018) Prognostic Value of Circulating KRAS2 Gene Mutations in Colorectal Cancer with Distant Metastases. The International Journal of Biological Markers 21:4, pages 223-228.
Crossref
Carlos Camps Herrero, Pilar Bayo Zaera, Rafael Sirera Pérez, Eva Sancho Salvador, Ana Blasco Cordellat & María José Safont Aguilera. (2005) Análisis de la concentración sérica del ADN tumoral en el cáncer de pulmón no microcítico y avanzado: ¿es útil como factor pronóstico?Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor?. Clinical and Translational Oncology 7:3, pages 122-126.
Crossref
K. S. Tagore, T. R. Levin & M. J. Lawson. (2004) The evolution to stool DNA testing for colorectal cancer. Alimentary Pharmacology & Therapeutics 19:12, pages 1225-1233.
Crossref
J. Otsuka, T. Okuda, A. Sekizawa, S. Amemiya, H. Saito, T. Okai & M. Kushima. (2004) Detection of p53 mutations in the plasma DNA of patients with ovarian cancer. International Journal of Gynecological Cancer 14:3, pages 459-464.
Crossref
James T. Wu. 2004. Cancer Diagnostics. Cancer Diagnostics 65 84 .
Seiji Ito, Kenji Hibi, Hiroshi Nakayama, Yasuhiro Kodera, Katsuki Ito, Seiji Akiyama & Akimasa Nakao. (2005) Detection of Tumor DNA in Serum of Colorectal Cancer Patients. Japanese Journal of Cancer Research 93:11, pages 1266-1269.
Crossref
Thierry Lecomte, Anne Berger, Franck Zinzindohoué, Stéphanie Micard, Bruno Landi, Hélène Blons, Philippe Beaune, Paul-Henri Cugnenc & Pierre Laurent-Puig. (2002) Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. International Journal of Cancer 100:5, pages 542-548.
Crossref
Tsu-Lan Wu, Diana Zhang, Ju-Hsin Chia, Kuo-Chien Tsao, Chien-Feng Sun & James T. Wu. (2002) Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clinica Chimica Acta 321:1-2, pages 77-87.
Crossref
Ming Li, Wen-hui Wan & Jin Gu. (2002) Detection of tumor mutant DNA in plasma of patient with colorectal cancer. Chinese Journal of Cancer Research 14:2, pages 154-156.
Crossref
J. Walker & P. Quirke. (2002) Prognosis and response to therapy in colorectal cancer. European Journal of Cancer 38:7, pages 880-886.
Crossref
Kenji Hibi, Hiroshi Nakayama, Taiji Yamazaki, Tsunenobu Takase, Masumi Taguchi, Yasushi Kasai, Katsuki Ito, Seiji Akiyama & Akimasa Nakao. (2001) Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. International Journal of Cancer 94:3, pages 429-431.
Crossref
Julie Walker & Phil Quirke. (2001) Biology and genetics of colorectal cancer. European Journal of Cancer 37, pages 163-172.
Crossref
DAMIÁN GARCÍA-OLMO & DOLORES C. GARCÍA-OLMO. (2006) Functionality of Circulating DNA. Annals of the New York Academy of Sciences 945:1, pages 265-275.
Crossref
ANATOLY V. LICHTENSTEIN, HOVSEP S. MELKONYAN, L. DAVID TOMEI & SAMUIL R. UMANSKY. (2006) Circulating Nucleic Acids and Apoptosis. Annals of the New York Academy of Sciences 945:1, pages 239-249.
Crossref
C. Salbe, C. Trevisiol, E. Ferruzzi, T. Mancuso, R. Nascimbeni, F. Di Fabio, B. Salerni & R. Dittadi. (2018) Molecular Detection of Codon 12 K-RAS Mutations in Circulating DNA from Serum of Colorectal Cancer Patients. The International Journal of Biological Markers 15:4, pages 300-307.
Crossref
Irina Botezatu, Ol’ga Serdyuk, Galina Potapova, Valery Shelepov, Raisa Alechina, Yuriy Molyaka, Vitaliy Anan’ev, Igor Bazin, August Garin, Mehti Narimanov, Vasiliy Knysh, Hovsep Melkonyan, Samuil Umansky & Anatoly Lichtenstein. (2000) Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism. Clinical Chemistry 46:8, pages 1078-1084.
Crossref
CHRISTOPHER D. GOCKE, FLOYD A. BENKO, MICHAEL S. KOPRESKI & THOMAS J. McGARRITY. (2006) p53 and APC Mutations Are Detectable in the Plasma and Serum of Patients with Colorectal Cancer (CRC) or Adenomas. Annals of the New York Academy of Sciences 906:1, pages 44-50.
Crossref
B. M. RYAN, R. O. McMANUS, J. S. DALY, P. W. N. KEELING, D. G. WEIR, F. LEFORT & D. KELLEHER. (2006) Serum Mutant K-ras in the Colorectal Adenoma-to-Carcinoma Sequence: Implications for Diagnosis, Postoperative Follow-up, and Early Detection of Recurrent Disease. Annals of the New York Academy of Sciences 906:1, pages 29-30.
Crossref
GEORGE D. SORENSON. (2006) A Review of Studies on the Detection of Mutated KRAS2 Sequences as Tumor Markers in Plasma/Serum of Patients with Gastrointestinal Cancer. Annals of the New York Academy of Sciences 906:1, pages 13-16.
Crossref
JIN JEN, LI WU & DAVID SIDRANSKY. (2006) An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum. Annals of the New York Academy of Sciences 906:1, pages 8-12.
Crossref
Jacques B de Kok, Theo J M Ruers, Goos N P van Muijen, Adrie van Bokhoven, Hans L Willems & Dorine W Swinkels. (2000) Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues. Clinical Chemistry 46:3, pages 313-318.
Crossref
Dorine W Swinkels, Jacques B de Kok, Anton Hanselaar, Karel Lamers & Rudolf H Boerman. (2000) Early Detection of Leptomeningeal Metastasis by PCR Examination of Tumor-derived K-ras DNA in Cerebrospinal Fluid. Clinical Chemistry 46:1, pages 132-133.
Crossref
M Fleischhacker, T Beinert & K Possinger. (1999) Molecular genetic characteristics of lung cancer?useful as ?real? tumor markers?. Lung Cancer 25:1, pages 7-24.
Crossref
Jacques B de KokJan C M HendriksWouter W van Solinge, Hans L WillemsEwald J MensinkDorine W Swinkels. (1998) Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods. Clinical Chemistry 44:10, pages 2201-2204.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.